Kodiak Sciences (KOD)
(Delayed Data from NSDQ)
$2.20 USD
-0.04 (-1.79%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $2.19 -0.01 (-0.45%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Cash flow Statements
Fiscal Year End for Kodiak Sciences Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -260.49 | -333.82 | -266.99 | -133.10 | -47.37 |
Depreciation/Amortization & Depletion | 25.11 | 9.99 | 8.79 | 4.21 | 0.67 |
Net Change from Assets/Liabilities | -7.36 | 11.96 | 14.43 | 14.79 | 1.44 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 88.56 | 105.42 | 61.51 | 30.67 | 6.11 |
Net Cash From Operating Activities | -154.18 | -206.46 | -182.27 | -83.43 | -39.15 |
Property & Equipment | -41.43 | -47.36 | -63.30 | -7.00 | -0.44 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 290.65 | -289.77 | 24.50 | 111.83 | -136.56 |
Other Investing Activities | 0.00 | 0.62 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 249.23 | -336.51 | -38.80 | 104.83 | -137.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.24 | 1.94 | 8.23 | 617.78 | 299.77 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | -0.01 | -0.05 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.21 | -0.05 | -0.05 | 99.61 | -0.04 |
Net Cash from Financing Activities | 0.03 | 1.90 | 8.18 | 717.38 | 299.69 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 95.07 | -541.08 | -212.89 | 738.78 | 123.54 |
Cash at Beginning of Period | 196.76 | 737.83 | 950.72 | 211.94 | 88.39 |
Cash at End of Period | 291.83 | 196.76 | 737.83 | 950.72 | 211.94 |
Diluted Net EPS | -4.97 | -6.39 | -5.16 | -2.91 | -1.25 |
Fiscal Year End for Kodiak Sciences Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -43.04 | -260.49 | -200.98 | -150.97 | -70.78 |
Depreciation/Amortization & Depletion | 6.65 | 25.11 | 18.44 | 11.47 | 5.14 |
Net Change from Assets/Liabilities | -21.76 | -7.36 | -4.82 | -1.15 | -7.56 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 18.55 | 88.56 | 65.41 | 51.47 | 25.98 |
Net Cash From Operating Activities | -39.60 | -154.18 | -121.94 | -89.18 | -47.22 |
Property & Equipment | -0.02 | -41.43 | -13.94 | -13.72 | -12.25 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 290.65 | 290.65 | 290.65 | 185.65 |
Other Investing Activities | -0.14 | 0.00 | 0.31 | 0.31 | 0.00 |
Net Cash from Investing Activities | -0.17 | 249.23 | 277.02 | 277.25 | 173.41 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.04 | 0.24 | 0.19 | 0.19 | 0.01 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | -0.21 | -0.04 | -0.02 | -0.01 |
Net Cash from Financing Activities | 0.04 | 0.03 | 0.16 | 0.17 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -39.73 | 95.07 | 155.24 | 188.24 | 126.18 |
Cash at Beginning of Period | 291.83 | 196.76 | 196.76 | 196.76 | 196.76 |
Cash at End of Period | 252.10 | 291.83 | 351.99 | 384.99 | 322.94 |
Diluted Net EPS | -0.82 | -1.14 | -0.95 | -1.53 | -1.35 |